MedPath

Evaluation the effect of one stage full mouth disinfection on serum IL17 and IL23 levels in patients with moderate to severe chronic periodontitis

Phase 3
Conditions
periodontitis.
Chronic periodontitis
Registration Number
IRCT201103165900N3
Lead Sponsor
Hamedan dental faculty
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
33
Inclusion Criteria

1- patients aged 25 to 70 years
2- Having at least 12 teeth (regardless of third molars, teeth with orthodontic appliances, crowns, bridges and implants)
3- Diagnosis of moderate to advanced chronic periodontitis
4- having informed consent.
Exclusion criteria:
1- Patients with a contra-indication for surgery or local anesthesia or scaling
2- Systemic disease (eg diabetes mellitus, cancer, AIDS, metabolic bone disease, diseases that delay the healing pockets, previous radiotherapy or immunosuppressive treatment, autoimmune diseases, allergies, infectious diseases, neutropenia, bleeding disorders, Rheumatoid arthritis, bowel disease, lung disease, multiple sclerosis)
3- pregnancy or lactation
4- History of systemic antibiotics use in the past six months
5- History of continuous use of NSAIDS in the past six months
6- scaling and root planning in the past year
7- contagious diseases
8- History of smoking in the past six months

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum levels of IL-17. Timepoint: 6 weeks later. Method of measurement: laboratory assessment (IL-17 ELISA kit).
Secondary Outcome Measures
NameTimeMethod
Serum IL-23 level. Timepoint: 6 weeks later. Method of measurement: laboratory assessment (IL-23 ELISA kit).
© Copyright 2025. All Rights Reserved by MedPath